Sarepta Therapeutics Inc (NASDAQ:SRPT)

79.99
Delayed Data
As of Apr 20
 +1.44 / +1.83%
Today’s Change
28.82
Today|||52-Week Range
84.37
+43.76%
Year-to-Date

Today’s Trading

Previous close78.55
Today’s open78.21
Day’s range77.67 - 80.87
Volume1,297,319
Average volume (3 months)1,499,094
Market cap$4.8B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+84.34%
Earnings growth (this year)-30.46%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+2,751.58%
P/E ratioNM
Price/Sales21.17
Price/Book6.10

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-1.39-1.60%
LOXOLoxo Oncology Inc-0.39-0.29%
RAREUltragenyx Pharmaceu...+0.39+0.72%
IRWDIronwood Pharmaceuti...-0.29-1.65%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$154.6M
Annual profit (last year)-$50.7M
Net profit margin-32.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts